Recent Finacing
Recent Raise
One Biosciences develops OneMap, an AI-driven single-cell transcriptomic platform for clinical-grade tumor profiling from standard samples to decode heterogeneity and inform treatment selection and therapy development.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at One Biosciences.